"Receptors, Purinergic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cell surface proteins that bind PURINES with high affinity and trigger intracellular changes which influence the behavior of cells. The best characterized classes of purinergic receptors in mammals are the P1 receptors, which prefer ADENOSINE, and the P2 receptors, which prefer ATP or ADP.
| Descriptor ID |
D011983
|
| MeSH Number(s) |
D12.776.543.750.695.700 D12.776.543.750.720.700
|
| Concept/Terms |
Receptors, Purinergic- Receptors, Purinergic
- Receptors, Purine
- Purine Receptors
- Purinoceptors
- Purinoceptor
- Purine Receptor
- Receptor, Purine
- Purinergic Receptors
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Purinergic".
Below are MeSH descriptors whose meaning is more specific than "Receptors, Purinergic".
This graph shows the total number of publications written about "Receptors, Purinergic" by people in this website by year, and whether "Receptors, Purinergic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Receptors, Purinergic" by people in Profiles.
-
Possible role of purinergic signaling in COVID-19. Mol Cell Biochem. 2021 Aug; 476(8):2891-2898.
-
New Horizons: Does Mineralocorticoid Receptor Activation by Cortisol Cause ATP Release and COVID-19 Complications? J Clin Endocrinol Metab. 2021 03 08; 106(3):622-635.
-
Purinergic Signaling of ATP in COVID-19 Associated Guillain-Barré Syndrome. J Neuroimmune Pharmacol. 2021 03; 16(1):48-58.
-
Potential Therapeutic Role of Purinergic Receptors in Cardiovascular Disease Mediated by SARS-CoV-2. J Immunol Res. 2020; 2020:8632048.
-
Inflammation and thrombosis in COVID-19 pathophysiology: proteinase-activated and purinergic receptors as drivers and candidate therapeutic targets. Physiol Rev. 2021 04 01; 101(2):545-567.
-
Purinergic Signaling: A New Pharmacological Target Against Viruses? Trends Pharmacol Sci. 2018 11; 39(11):926-936.
-
Purinergic signaling inhibits human acute myeloblastic leukemia cell proliferation, migration, and engraftment in immunodeficient mice. Blood. 2012 Jan 05; 119(1):217-26.